I wouldn't tell the clinics yet. On your own pre-registered rule, v2.4 doesn't clear everything, and there is a patient-safety problem to fix first.

**1. Dosing accuracy: v2.4 fails.**
- The rule was "no worse than v2.3 on dosing accuracy". The pharmacy tech's line-by-line check found two v2.4 tables where a twice-daily drug was written as once daily, and none in v2.3. That makes v2.4 worse.
- The judges' 5.0 for both versions doesn't settle it. A 5.0 from judges reading for overall quality doesn't mean they checked every frequency against the source notes, and the tech did. A systematic check against the source is better evidence than a rating, and a dosing error can under-dose an animal.
- Two errors in 24 outputs is about 8%. That is small, but it comes from a new feature (the schedule table), so it probably recurs. Across 14 clinics the errors would reach owners.
- Dr. Achterberg wrote v2.4 and was also a judge, so she was rating her own work. I'm not suggesting bad faith, but it is another reason to weight the independent check more heavily than the judges' scores.

**2. Clarity: the bar change.**
- v2.4 is ahead by 0.8, which misses the 1.0 you set on September 2. You lowered the bar to 0.5 on September 10, a day after the results, and 0.8 now passes.
- Your reasoning may be right, since 1.0 on a 7-point scale is arguably too strict. But changing a threshold after seeing the result is exactly what pre-registering was meant to prevent, and anyone reviewing this later will see that.
- If you keep the change, record it openly as a post-hoc amendment and don't describe it as a pass on the original rule. A cleaner option is to re-test clarity with the 0.5 bar fixed in advance.
- With 12 cases and three judges, 0.8 is also a noisy estimate.

**3. The carprofen question: a warning sign.**
- This was an informal check, so don't over-read it. But v2.4 answered a simple question in two sentences, while v2.3 produced a full discharge sheet. That suggests v2.4 handles ad hoc owner questions differently. Whether that is better or worse depends on the use case.
- If DischargeWriter is only used to produce discharge sheets, this matters less. If owners or staff ever use it for follow-up questions, you'd want to know why the behavior changed. It's worth a quick look, but it isn't a blocker by itself.

**4. Length** is about even, so that criterion passes.

**What I'd do instead of going live Monday**
1. Have Dr. Achterberg look at the two once-daily/twice-daily errors and fix the table generation. Possible fixes are an explicit instruction to copy frequency verbatim from the notes, or a check step.
2. Re-run the 12 cases, ideally with new ones added, and have the pharmacy tech check dosing line by line again. Make the dosing criterion "zero frequency errors", which is a stricter and more meaningful test than a judges' score.
3. Re-score clarity under the 0.5 bar, stated before you run it, with judges who didn't write either version if you can.
4. If it passes, go live. That delay is probably days, not weeks.

**If you must ship Monday:** keep v2.3 live, or have a vet or nurse verify every v2.4 medication table before it goes to an owner. I wouldn't send unverified v2.4 tables out across 14 clinics.

**Suggested message to the clinics:** "DischargeWriter v2.4 shows better owner clarity, but testing found a medication-frequency error in its schedule tables. We are fixing and retesting it. v2.3 stays live until then."

I've assumed the tech's check covered all 24 outputs, and that the 5.0 scores came from clinical judgment rather than a line-by-line comparison. If the judges did check line by line and missed the errors, that is a bigger concern about the review process.
